Grupo de Investigacion en Superficie Ocular (GSO)
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (9)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation
International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30
2017
-
Designing lipid nanoparticles for topical ocular drug delivery
International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217
2014
-
Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing
International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20
2013
-
A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model
Gene Therapy, Vol. 20, Núm. 5, pp. 467-477
-
Biologic Therapy In Refractory Uveitis Of Behcet's Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients
ARTHRITIS AND RHEUMATISM
-
Short and Long-Term Biological Therapy In Refractory Uveitis Of Behcet's Syndrome. Multicenter Study Of 124 Patients
ARTHRITIS AND RHEUMATISM
2011
-
Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles
Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788